Arterys (Acquired by Tempus Labs) logo — Reinventing imaging so you can practice better and faster.

Arterys (Acquired by Tempus Labs)

Reinventing imaging so you can practice better and faster.

Founded 2013 United States San Francisco, United States 15 employees Series C Total: $71.72M Computing, Health Care +1

General Information

Company Name Arterys (Acquired by Tempus Labs)
Founded Year 2013
Location United States San Francisco, United States
Employees 15
Industries Computing, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Arterys (Acquired by Tempus Labs). To contact Arterys (Acquired by Tempus Labs), visit arterys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arterys (Acquired by Tempus Labs) compare?

A PDF of Arterys (Acquired by Tempus Labs) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arterys (Acquired by Tempus Labs) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arterys (Acquired by Tempus Labs)

Arterys, founded in 2013, aims to revolutionize medical imaging through data, artificial intelligence, and technology. The company has received 8 FDA clearances and operates in 118 countries, setting the bar for cloud-based AI products. Arterys addresses radiologists' workload, tool accuracy, and practice consistency, offering a comprehensive set of clinical AI solutions. The latest investment of $28.00M in a Series C round on 29 May 2020 involved prominent investors such as Emergent Medical Partners, Fosun Capital, Temasek Holdings, Revelation Partners, Varian, and Benslie Investment Group. With head offices in the United States, Arterys continues to expand its presence globally. This company is at the forefront of transforming medical imaging for enhanced physician experience, patient outcomes, and healthcare efficiency. For more information, visit www.arterys.com.

Taxonomy: Medical Imaging, Radiology, FDA Clearance, Clinical AI Solutions, Deep Learning, Quantification, MRI, Healthcare Innovation, Global Medicine

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $28.00M 6
Emergent Medical Partners, Fosun Capital +4
29 May 2020
Convertible Note Undisclosed 1
Asset Management Ventures
24 Jul 2019
Series B $30.00M 8
GE Ventures, Emergent Medical Partners +6
15 Nov 2017
Grant Undisclosed 1
MedTech Innovator
01 May 2017
Series A $5.00M 7
Asset Management Ventures, AME Cloud Ventures +5
14 Mar 2016
Series A $7.00M 5
Asset Management Ventures, AME Cloud Ventures +3
07 Dec 2015
Venture Round Undisclosed 1
Morado Ventures
08 Apr 2014
Seed Round Undisclosed 2
Asset Management Ventures, Farzad Nazem
25 Jun 2013
Seed Round $1.72M 2
Asset Management Ventures, Morado Ventures
22 Jan 2013

Arterys (Acquired by Tempus Labs) Alternatives & Competitors

View All Alternatives
Arterys (Acquired by Tempus Labs) vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology
Arterys (Acquired by Tempus Labs) vs

The Swoop® system brings MR brain imaging within reach. Nasdaq: $HYPR

Grant
155 employees
Health Care, IT
Arterys (Acquired by Tempus Labs) vs
Promaxo
Promaxo United States

We are transforming the lives of patients and doctors through our single-sided portable MRI. Fast, s...

Venture round
94 employees
Health Care, Health and Wellness

FAQ About Arterys (Acquired by Tempus Labs)

Reinventing imaging so you can practice better and faster.
Arterys (Acquired by Tempus Labs) was founded in 2013.
Arterys (Acquired by Tempus Labs) is headquartered in San Francisco, United States.
Arterys (Acquired by Tempus Labs) operates in Computing, Health Care and Medical Devices. Its work centres on Medical Imaging, Radiology, FDA Clearance and Clinical AI Solutions.
Arterys (Acquired by Tempus Labs) has approximately 15 employees.
Arterys (Acquired by Tempus Labs) has completed 9 funding rounds, raising a total of $71.72M. The latest funding stage is Series C.
Top alternatives and competitors to Arterys (Acquired by Tempus Labs) include CureMetrix, Hyperfine | AI-Powered Portable MRI, Promaxo, INCEPTO, Sirius Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arterys (Acquired by Tempus Labs) and CureMetrix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arterys (Acquired by Tempus Labs), https://bouncewatch.com/company/arterys, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes